Published in J Med Virol on June 01, 2006
Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis (2009) 2.62
Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis (2013) 1.25
Acute hepatitis E virus infection in an HIV-infected person in the United States. Ann Intern Med (2009) 1.05
Profile of acute infectious markers in sporadic hepatitis E. PLoS One (2010) 1.04
Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J Clin Microbiol (2007) 0.99
Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A. Eur J Clin Microbiol Infect Dis (2008) 0.96
Hepatitis E: a complex and global disease. Emerg Health Threats J (2008) 0.89
Transmission, diagnosis, and management of hepatitis E: an update. Hepat Med (2014) 0.86
Characterization of Two Novel Linear B-Cell Epitopes in the Capsid Protein of Avian Hepatitis E Virus (HEV) That Are Common to Avian, Swine, and Human HEVs. J Virol (2015) 0.78
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol (2006) 10.21
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep (2005) 5.70
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep (2006) 5.63
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Ebola 2014--new challenges, new global response and responsibility. N Engl J Med (2014) 5.23
Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev (2006) 5.13
Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med (2007) 4.69
A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol (2005) 4.48
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol (2002) 4.20
An outbreak of hepatitis A associated with green onions. N Engl J Med (2005) 3.89
Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 3.77
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med (2014) 3.50
Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ (2003) 2.99
Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology (2004) 2.78
The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS (2004) 2.74
Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology (2008) 2.66
Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis (2010) 2.62
Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis (2010) 2.57
Incidence of hepatitis A in the United States in the era of vaccination. JAMA (2005) 2.42
Health care-associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis (2011) 2.36
Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border. Clin Infect Dis (2012) 2.32
Surveillance for foodborne disease outbreaks - United States, 1998-2008. MMWR Surveill Summ (2013) 2.27
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology (2005) 2.24
Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med (2002) 2.11
Hepatitis B virus transmissions associated with a portable dental clinic, West Virginia, 2009. J Am Dent Assoc (2013) 2.07
Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis (2002) 2.06
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis (2008) 1.86
Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite development. J Cell Sci (2003) 1.78
Hepatitis A in the era of vaccination. Epidemiol Rev (2006) 1.75
Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis (2009) 1.66
Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health (2002) 1.61
Hepatitis A among international adoptees and their contacts. Clin Infect Dis (2008) 1.60
Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis (2008) 1.57
Chronic liver disease mortality in the United States, 1990-1998. Hepatology (2004) 1.55
The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol (2008) 1.55
National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis (2008) 1.55
An outbreak of wild poliovirus in the Republic of Congo, 2010-2011. Clin Infect Dis (2012) 1.53
Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker. Am J Infect Control (2003) 1.53
Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001. Emerg Infect Dis (2002) 1.51
Population-based surveillance for acute liver failure. Am J Gastroenterol (2007) 1.51
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend (2007) 1.50
Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med (2005) 1.43
Hepatitis E epidemic, Uganda. Emerg Infect Dis (2010) 1.41
The increasing burden of imported chronic hepatitis B--United States, 1974-2008. PLoS One (2011) 1.37
2008 outbreak of Salmonella Saintpaul infections associated with raw produce. N Engl J Med (2011) 1.36
Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006. Arch Intern Med (2011) 1.35
Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. Emerg Infect Dis (2002) 1.34
Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics (2002) 1.30
Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility. Am J Public Health (2005) 1.28
Possible eradication of wild poliovirus type 3--worldwide, 2012. MMWR Morb Mortal Wkly Rep (2014) 1.27
Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001. Emerg Infect Dis (2002) 1.27
Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis (2012) 1.25
Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad. J Med Virol (2005) 1.24
Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J (2008) 1.20
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis (2014) 1.17
Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment. Hepatology (2008) 1.17
Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis (2008) 1.16
Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J (2005) 1.14
Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis (2011) 1.13
Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics (2007) 1.13
National outbreak of Salmonella serotype saintpaul infections: importance of Texas restaurant investigations in implicating jalapeño peppers. PLoS One (2011) 1.10
Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics (2007) 1.10
Outbreak of lower respiratory tract illness associated with human enterovirus 68 among American Indian children. Pediatr Infect Dis J (2012) 1.08
Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics (2012) 1.08
An assessment of the performance of self-reported vaccination status for hepatitis B, National Health and Nutrition Examination Survey 1999-2008. Am J Public Health (2013) 1.08
Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. Bull World Health Organ (2007) 1.08
Identification of patients with hepatitis C virus infection in New Haven County primary care practices. J Clin Gastroenterol (2003) 1.08
Salmonella typhimurium infections associated with peanut products. N Engl J Med (2011) 1.08
Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States. J Clin Microbiol (2011) 1.07
Prevalence of infection with waterborne pathogens: a seroepidemiologic study in children 6-36 months old in San Juan Sacatepequez, Guatemala. Am J Trop Med Hyg (2004) 1.07
One-step real-time PCR assay for detection and quantitation of hepatitis D virus RNA. J Virol Methods (2013) 1.07
Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002-2003. Infect Control Hosp Epidemiol (2007) 1.06
Molecular epidemiology of foodborne hepatitis a outbreaks in the United States, 2003. J Infect Dis (2005) 1.06
Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. Drug Alcohol Depend (2005) 1.06
Hepatitis a molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy. J Infect Dis (2005) 1.06
The science behind preparing and responding to pandemic influenza: the lessons and limits of science. Clin Infect Dis (2011) 1.04
Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine (2004) 1.04
Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007. J Acquir Immune Defic Syndr (2010) 1.04
Non-pharmaceutical interventions during an outbreak of 2009 pandemic influenza A (H1N1) virus infection at a large public university, April-May 2009. Clin Infect Dis (2011) 1.03
SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis (2004) 1.03
Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001. Emerg Infect Dis (2003) 1.02
Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study. J Clin Virol (2012) 1.02
An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment. Addiction (2006) 1.01
Human Salmonella infections linked to contaminated dry dog and cat food, 2006-2008. Pediatrics (2010) 1.00
Parental knowledge, attitudes, and practices associated with not receiving hepatitis A vaccine in a demonstration project in Butte County, California. Pediatrics (2003) 0.99